Ref.: BL-RE-091260Manufacturer ref.: EHKLK6X5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA Kallikrein 6 sandwich (Hu KLK6) (human): quantitative determination of Hu KLK6 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK6.
Accession number
Q92876
Dose range
0.614 ng/ml to 150 ng/ml
Sensitivity of the dosage
0.6 ng/ml
Calibration range
0.6 ng/ml to 150 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Kallikrein 6 sandwich (Hu KLK6) (human): quantitative determination of Hu KLK6 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK6.
Kit ELISA Kallikrein 6 sandwich (Hu KLK6) (human): quantitative determination of Hu KLK6 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK6.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Kallikreins are a subset of serin proteases with various physiological functions. Kallikrein 6, or KLK6, showed activity against amyloid precursor proteins, myelin base proteins, gelatin, casein, and extracellular matrix proteins such as fibronectin, laminin, vitronectin, and collagen. It degrades alpha-synuclein and prevents polymerization, indicating that it may be involved in the pathogenesis of Parkinson's disease and other synucleinopathy. KLK6 may be involved in regulating the exgrowth of the spinal cord following spinal cord injury. It has also been shown that KLK6 promotes cell proliferation, migration and invasion and is regulated upwards in several types of cancers, including colon and lovarian cancers.
Sensitivity
Sensitivity of dosage: 0.6 ng/ml.
Measurement range
Dose range: 0.614 ng/ml to 150 ng/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This ELISA antibody detects human KLK6. Other species not yet determined.